Standard BioTools Inc. Common Stock

LABNASDAQ • USD
ThemeGenomics & Precision Med.›Precision Medicine Platforms
1.15 USD
↘ 0.12 (9.45%)AT CLOSE (11:59 AM EDT)
1.11
↘ 0.05 (3.91%)
POST MARKET (AS OF 07:50 PM EDT)
Post Market
AS OF 07:50 PM EDT
1.11
↘ 0.05 (3.91%)
🔴Market: CLOSED
Open?$1.27
High?$1.28
Low?$1.11
Prev. Close?$1.27
Volume?3.5M
Avg. Volume?2.4M
VWAP?$1.15
Rel. Volume?1.46x
Bid / Ask
Bid?$1.05 × 1.5K
Ask?$1.16 × 100
Spread?$0.11
Midpoint?$1.11
Valuation & Ratios
Market Cap?448.9M
Shares Out?390.4M
Float?222.7M
Float %?57.1%
P/E Ratio?5.74
P/B Ratio?0.80
EPS?$0.20
Dividend?0.00%
Ex-Dividend?N/A

Shares of Standard BioTools Inc. Common Stock (LAB) are trading at $1.15. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". Notable factors include a concerning Altman Z-Score in the distress zone and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.
Themes
Healthcare - Genomics & Precision Medicine›Precision Medicine Platforms
Employees
389
Market Cap
448.9M
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Website
www.standardbio.com
Listed
2011-02-10
Address
50 MILK STREET
BOSTON, MA 02109
Phone: (650) 266-6000
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
21
Momentum?
43
Short Sent.?
57
Piotroski F-Score?5/9Mixed
Altman Z-Score?1.51Distress
Confidence?67%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?5.80%Elevated
Short Interest?12.9M
Days to Cover?7.0
Free Float222.7M
Avg Daily Volume1.8M
Settlement Date2026-05-15
Financial Health
Current Ratio?12.36Strong
Quick Ratio?11.92Strong
Cash Ratio?6.30Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
93/100
P/E?
Peers
100
S&P
97
5.7CHEAP▾
P/B?
Peers
100
S&P
97
0.80CHEAP▾
P/S?
Peers
100
S&P
28
5.20FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.6CHEAP▾
EV/Sales?
Peers
100
S&P
73
2.13CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
51
13.9%STRONG▾
ROA?
Peers
50
S&P
81
12.2%STRONG▾
Cash Flow & Enterprise
FCF?$-94476000
Enterprise Value?$183.5M
Fundamentals ratios updated end of day
MarketsMoversWatchlist